Stocks · Health care · Pharmaceutical Preparations

Edesa Biotech, Inc.

EDSA Clue Score49
British Columbia, Canada Fiscal year ends September CIK 0001540159 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Pardeep Nijhawan
10 Mar 2026
Chief Executive Officer
Buy
1,000
$6.60
$6.60K
Pardeep Nijhawan
5 Mar 2026
Chief Executive Officer
Buy indirect
10,000
$3.90
$39.00K
Pardeep Nijhawan
4 Mar 2026
Chief Executive Officer
Buy indirect
10,000
$4.26
$42.56K
Pardeep Nijhawan
3 Mar 2026
Chief Executive Officer
Buy indirect
10,000
$3.63
$36.30K
Pardeep Nijhawan
2 Mar 2026
Chief Executive Officer
Buy indirect
1,000
$2.28
$2.28K
Pardeep Nijhawan
2 Mar 2026
Chief Executive Officer
Buy
2,000
$2.00
$4.00K
Pardeep Nijhawan
27 Feb 2026
Chief Executive Officer
Buy indirect
30,000
$2.22
$66.70K
Pardeep Nijhawan
26 Feb 2026
Chief Executive Officer
Buy
20,571
$1.58
$32.48K
Michael J Brooks
26 Feb 2026
President
Buy
2,000
$1.57
$3.14K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 689,307
History held since 13 Nov 2014